Brad McClimon is a Rheumatology/Immunology physician. OpenAlex indexes 11 publications with 1,335 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SANOFI-AVENTIS U.S. LLCProgram year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20241 payment
- SANOFI-AVENTIS U.S. LLCProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
81.4%Corticosteroid43.7%Fluticasone Propionate40%Breo Ellipta16%Arnuity Ellipta12%Symbicort7%Trelegy Ellipta6%Breztri Aerosphere5%Budesonide-Formoterol Fumarate5%Breyna2%Qvar Redihaler2%Budesonide2%Dulera2%Part D<11 patientsLeukotriene Receptor Antagonist18.9%Montelukast Sodium100%Part D≥55 patients+ 4 more classes in this area
Metabolism & gastrointestinal
8.4%Corticosteroid8.4%Prednisone100%Part D≥57 patientsAnti-infectives
5.4%Tetracycline-class Drug1.8%Doxycycline Monohydrate52%Doxycycline Hyclate48%Part D<11 patientsCephalosporin Antibacterial1.7%Cefdinir52%Cefuroxime48%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Game Changers? MACRA, APM, The Future of the ACA: Where does the allergist go from here?
2017 AAAAI Annual Meeting
2017 - The predictive value of skin testing in the diagnosis of local anesthetic allergy
Allergy and Asthma Proceedings
2011 - Collaboration between Allergists and Pharmacists Increases β-Lactam Antibiotic Prescriptions in Patients with a History of Penicillin Allergy
International Archives of Allergy and Immunology
2010 - RESOLUTION OF HYPOGAMMAGLOBULINEMIA AFTER RESECTION OF RENAL CELL CARCINOMA
Annals of Allergy Asthma & Immunology
2009
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
David Felson, MD
Boston University
Marc Hochberg, MD
University of Maryland School of Medicine
Philip Mease, MD
Michelle Petri, MD
Johns Hopkins University School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”